105
Participants
Start Date
December 31, 2006
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
Morphine, Parecoxib
Parecoxib 40 milligrams (mg) administered intravenously immediately post surgery, followed 20 mg every 12 hours until 48 hours post surgery, total 5 doses. Participants also received Patient-Controlled Analgesia (PCA) 1 mg per dose, maximum 40 mg/4 hours, and if necessary, bolus (2 to 5 mg) before or after enabled PCA.
Morphine, Placebo
Matching placebo administered intravenously immediately post surgery and every 12 hours until 48 hours post surgery, total 5 doses. Participants also received PCA (1 mg per dose, maximum 40 mg/4 hours, and if necessary, bolus (2 to 5 mg) before or after enabled PCA
Pfizer Investigational Site, Essen
Pfizer Investigational Site, Cologne
Pfizer Investigational Site, Heidelberg
Pfizer Investigational Site, Reutlingen
Lead Sponsor
Pfizer
INDUSTRY